Showing results (21-30 of 79) with videos related to
Sort By:
Pageof 8
Neurobiology of Disease|July 9, 2023
Mechanisms of pathogenesis and environmental moderators in preclinical models of compulsive-like behavioursCarey Wilson, James J Gattuso, Anthony J Hannan, et al.Neurochemical Research|April 5, 2007
Life-long hippocampal neurogenesis: environmental, pharmacological and neurochemical modulationsEleni Paizanis, Sabah Kelaï, Thibault Renoir, et al.The European Journal of Neuroscience|December 9, 2025
Acute Blockade of the Serotonin Transporter With Low Doses of Escitalopram Does Not Alter the Behavioural Responses to Acute PsilocybinNina Kleditzsch, James J Gattuso, Anthony J Hannan, et al.Journal of Huntington'S Disease|April 24, 2023
Implications of Tau Dysregulation in Huntington's Disease and Potential for New TherapeuticsIsaline Mees, Rebecca M Nisbet, Anthony J Hannan, et al.Neuropharmacology|November 3, 2024
Psilocybin reduces grooming in the SAPAP3 knockout mouse model of compulsive behaviourJames J Gattuso, Carey Wilson, Anthony J Hannan, et al.Neuropharmacology|August 19, 2023
Acute administration of the NMDA receptor antagonists ketamine and MK-801 reveals dysregulation of glutamatergic signalling and sensorimotor gating in the Sapap3 knockout mouse model of compulsive-like behaviourJames J Gattuso, Carey Wilson, Anthony J Hannan, et al.Journal of Neurochemistry|November 29, 2023
Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic reviewJames J Gattuso, Carey Wilson, Anthony J Hannan, et al.Neuropharmacology|February 16, 2017
Environmental enrichment enhances cognitive flexibility in C57BL/6 mice on a touchscreen reversal learning taskAriel Zeleznikow-Johnston, Emma L Burrows, Thibault Renoir, et al.Advances in Neurobiology|July 5, 2017
Huntington's Disease: Pathogenic Mechanisms and Therapeutic TargetsDean J Wright, Thibault Renoir, Laura J Gray, et al.Pharmacology, Biochemistry, and Behavior|October 16, 2014
Sexually dimorphic dopaminergic dysfunction in a transgenic mouse model of Huntington's diseaseThibault Renoir, Andrew Argyropoulos, Caroline Chevarin, et al.Pageof 8